Search

everythinglearnresearchcommunity

for

Search:↓

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

Some drugs can cause skin and hair color changes, often reversible when the drug is stopped.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

Metformin may help treat neuroendocrine tumors.

Synthetic antioxidants are effective, cheap, and stable, with some like zinc and cholecalciferol reducing child and cancer deaths, but the safety of additives like BHA, BHT, TBHQ, and PEG needs more research.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

A specific gene variant is linked to a higher risk of hair loss from chemotherapy in breast cancer patients.

Nitric Oxide has potential in medicine, especially for infections and heart treatments, but its short life and delivery challenges limit its use.

Organic and biogenic nanocarriers can improve drug delivery but face challenges like consistency and safety.

The new chemotherapy combination of WP 631 and Epothilone B shows enhanced effectiveness against ovarian cancer but requires more research on its safety.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

New nanocarriers improve drug delivery for disease treatment.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

Nanomaterials can improve hair care products and treatments, including hair loss and alopecia, by enhancing stability and safety, and allowing controlled release of compounds, but their safety in cosmetics needs more understanding.

CBD may improve skin and hair health, but its effective use and safety need more research.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

Topical treatments can deliver active molecules to skin stem cells, potentially helping treat skin and hair disorders, including skin cancers and hair loss.

Calreticulin has roles in healing, immune response, and disease beyond its known functions in the endoplasmic reticulum.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Injectable hydrogels are becoming increasingly useful in medicine for drug delivery and tissue repair.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Some viruses can cause cancer by changing cell processes and avoiding the immune system; vaccines and targeted treatments help reduce these cancers.

The document concludes that understanding genetic mutations in the PI3K-AKT-mTOR pathway can lead to better diagnosis and treatment for certain genetic skin disorders.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.